March 12, 2019
InventisBio ensures $70M in Series C financing to speed up candidates clinical trials
InventisBio said Tuesday it raised $70 million in a Series C financing in January 2019, to accelerate the development of its clinical candidates into phase 2 trials and help us developfirst-in-class drug candidates into clinical stage.